Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MIRs03: A Double-blind Randomized Trial of Paravertebral Block With Ropivacaine Before Breast Cancer Surgery: Effects on Chronic Postoperative Pain

NCT02408393 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT02408393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02408393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MIRs03: A Double-blind Randomized Trial of Paravertebral Block With Ropivacaine Before Breast Cancer Surgery: Effects on Chronic Postoperative Pain
Lead sponsor
Institut Curie
Phase
Phase 3
Overall status
Completed
Start date
March 27, 2015
Completion date
March 9, 2019
Enrollment
380 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasm of breast